Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating
potential violations of the federal securities laws by Lannett Company,
Inc. (NYSE: LCI) and certain of its officers. Lannett develops,
manufactures, packages, markets, and distributes generic versions of
branded pharmaceutical products.
Specifically, Johnson & Weaver's investigation seeks to determine if
Lannett, through its business practices, violated antitrust laws.
On July 16, 2014, the Company made known that it has received
interrogatories and a subpoena from State of Connecticut Office of the
Attorney General in connection with an investigation into pricing of
digoxin, a treatment used for congestive heart failure. The Attorney
General's investigation will sek to determine "whether anyone engaged
in any activities that resulted in (a) fixing, maintaining or
controlling prices of digoxin or (b) allocating and dividing customers
or territories relating to the sale of digoxin in violation of
Connecticut antitrust law." On the news, Lannett shares declined more
than 17 percent on July 16, 2014.
If you are a Lannett shareholder and are interested in learning more
about the investigation or your legal rights and remedies, please
contact Jim Baker (email@example.com)
at 619-814-4471. If you email, please include your phone number.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law
firm with offices in California and New York. The firm represents
individual and institutional investors in shareholder derivative and
securities class action lawsuits. For more information about the firm
and its attorneys, please visit http://www.johnsonandweaver.com.
Attorney advertising. Past results do not guarantee future outcomes.
[ Back To NFVZone's Homepage ]